Jeannette E Davies
Overview
Explore the profile of Jeannette E Davies including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
572
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noble M, Mayer-Proschel M, Davies J, Davies S, Proschel C
Curr Opin Neurol
. 2011 Oct;
24(6):570-6.
PMID: 22027545
Purpose Of Review: Central to the obstacles to be overcome in moving promising cell-based therapies from the laboratory to the clinic is that of determining which of the many cell...
2.
Noble M, Davies J, Mayer-Proschel M, Proschel C, Davies S
Neurotherapeutics
. 2011 Sep;
8(4):677-93.
PMID: 21918888
This review summarizes current progress on development of astrocyte transplantation therapies for repair of the damaged central nervous system. Replacement of neurons in the injured or diseased central nervous system...
3.
Davies S, Shih C, Noble M, Mayer-Proschel M, Davies J, Proschel C
PLoS One
. 2011 Mar;
6(3):e17328.
PMID: 21407803
Repairing trauma to the central nervous system by replacement of glial support cells is an increasingly attractive therapeutic strategy. We have focused on the less-studied replacement of astrocytes, the major...
4.
Davies J, Proschel C, Zhang N, Noble M, Mayer-Proschel M, Davies S
J Biol
. 2008 Sep;
7(7):24.
PMID: 18803859
Background: Two critical challenges in developing cell-transplantation therapies for injured or diseased tissues are to identify optimal cells and harmful side effects. This is of particular concern in the case...
5.
Minor K, Tang X, Kahrilas G, Archibald S, Davies J, Davies S
Neurobiol Dis
. 2008 Jul;
32(1):88-95.
PMID: 18638554
Inhibitory chondroitin sulfate proteoglycans (CSPGs) and myelin-associated molecules are major impediments to axon regeneration within the adult central nervous system (CNS). Decorin infusion can however suppress the levels of multiple...
6.
Davies J, Huang C, Proschel C, Noble M, Mayer-Proschel M, Davies S
J Biol
. 2006 Apr;
5(3):7.
PMID: 16643674
Background: Transplantation of embryonic stem or neural progenitor cells is an attractive strategy for repair of the injured central nervous system. Transplantation of these cells alone to acute spinal cord...
7.
Davies J, Tang X, Bournat J, Davies S
J Neurotrauma
. 2006 Apr;
23(3-4):397-408.
PMID: 16629625
Spinal cord scar tissue presents a combined physical and molecular barrier to axon regeneration. Theoretically, spinal cord injuries (SCIs) can be rendered more permissive to axon growth by either suppressing...
8.
Davies J, Tang X, Denning J, Archibald S, Davies S
Eur J Neurosci
. 2004 Mar;
19(5):1226-42.
PMID: 15016081
The formation of misaligned scar tissue by a variety of cell types expressing multiple axon growth inhibitory proteoglycans presents a physical and molecular barrier to axon regeneration after adult spinal...
9.
Tang X, Davies J, Davies S
J Neurosci Res
. 2003 Jan;
71(3):427-44.
PMID: 12526031
Previous studies have correlated the failure of axon regeneration after spinal cord injury with axons contacting scar tissue rich in chondroitin sulfate proteoglycans (CSPGs; Davies et al., 1999). In the...
10.
Sussman C, Davies J, Miller R
Glia
. 2002 Sep;
40(1):55-64.
PMID: 12237843
Recent advances in understanding oligodendrocyte development have revealed the importance of both extra- and intracellular molecules in regulating the induction, survival, and proliferation of early oligodendrocyte progenitors. The signaling molecule...